| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 263 |
| 1 | METHOTREXATE | 238 |
| 2 | ADALIMUMAB | 229 |
| 3 | DEXAMETHASONE | 229 |
| 4 | DEXAMETHASONE 1.5 MG | 223 |
| 5 | PREDNISONE | 223 |
| 6 | TACROLIMUS | 217 |
| 7 | CYCLOPHOSPHAMIDE | 189 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 189 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 189 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NELARABINE | 42 | 0.0431 |
| 1 | CILTACABTAGENE AUTOLEUCEL | 61 | 0.0093 |
| 2 | CEFTAZIDIME | 29 | 0.0037 |
| 3 | BUSULFAN | 55 | 0.0035 |
| 4 | BRENTUXIMAB VEDOTIN | 35 | 0.0034 |
| 5 | DACARBAZINE | 23 | 0.0030 |
| 6 | MITOXANTRONE HYDROCHLORIDE | 19 | 0.0030 |
| 7 | IPILIMUMAB | 131 | 0.0030 |
| 8 | VINORELBINE | 20 | 0.0029 |
| 9 | ALEMTUZUMAB | 52 | 0.0027 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 686 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 345 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 299 |
| 3 | Alkylating Drug [EPC] | 270 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 258 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 250 |
| 6 | Platinum-based Drug [EPC] | 247 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 213 |
| 8 | Proton Pump Inhibitor [EPC] | 190 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 176 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Activation Gene-3 Blocker [EPC] | 4 | 0.0078 |
| 1 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 12 | 0.0055 |
| 2 | CD30-directed Immunoconjugate [EPC] | 35 | 0.0034 |
| 3 | Skin Test Antigen [EPC] | 6 | 0.0032 |
| 4 | Lymphocyte Growth Factor [EPC] | 4 | 0.0032 |
| 5 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 10 | 0.0031 |
| 6 | CTLA-4-directed Blocking Antibody [EPC] | 138 | 0.0029 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 52 | 0.0027 |
| 8 | Human Immunoglobulin G [EPC] | 52 | 0.0025 |
| 9 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 2 | 0.0024 |